Boratderivat und verwendungen davon

AT1932987TUndetermined Publication Date: 2026-07-15REISTONE BIOPHARMA CO LTD
View PDF -1 Cites -1 Cited by

Patent Information

Application Number
AT2021909545T
Authority / Receiving Office
AT · AT
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-11-26
Filing Date
2021-12-24
Publication Date
2026-07-15
Estimated Expiration
2041-12-24
Patent Text Reader

Abstract

Provided are a compound as represented by formula I or a pharmaceutically acceptable salt thereof, and applications of the compound in preparing a medicament for preventing and / or treating a PDE-related disorder.
Need to check novelty before this filing date? Find Prior Art